Assembly Biosciences, Inc.ASMBNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank95
3Y CAGR+286.2%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+286.2%/yr
vs -31.8%/yr prior
Acceleration
+318.0pp
Accelerating
Percentile
P95
Near historical high
vs 3Y Ago
57.6x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 193.66% |
| Q3 2025 | 9.45% |
| Q2 2025 | 28.50% |
| Q1 2025 | -5658.97% |
| Q4 2024 | 97.33% |
| Q3 2024 | 10.94% |
| Q2 2024 | 6.87% |
| Q1 2024 | -124.98% |
| Q4 2023 | 626.14% |
| Q3 2023 | -2.25% |
| Q2 2023 | 41.63% |
| Q1 2023 | -21.68% |
| Q4 2022 | 3.36% |
| Q3 2022 | -11.40% |
| Q2 2022 | 34.97% |
| Q1 2022 | -41.91% |
| Q4 2021 | -2.64% |
| Q3 2021 | 13.42% |
| Q2 2021 | 40.12% |
| Q1 2021 | -34.80% |
| Q4 2020 | -353.79% |
| Q3 2020 | 145.26% |
| Q2 2020 | 6.97% |
| Q1 2020 | -23.07% |
| Q4 2019 | -10.48% |
| Q3 2019 | 11.69% |
| Q2 2019 | 17.19% |
| Q1 2019 | -50.12% |
| Q4 2018 | -1.29% |
| Q3 2018 | -3.87% |
| Q2 2018 | -3.59% |
| Q1 2018 | -53.39% |
| Q4 2017 | 11.60% |
| Q3 2017 | 7.25% |
| Q2 2017 | -135.36% |
| Q1 2017 | 413.39% |
| Q4 2016 | -41.19% |
| Q3 2016 | -16.69% |
| Q2 2016 | 26.54% |
| Q1 2016 | -68.56% |